Blocking NRP-1 resulted in the downregulation of EMT markers (e.g., N-cadherin, vimentin) and the upregulation of E-cadherin, suggesting that NRP-1 plays an important role in cancer progression and increased invasiveness [25]. This evidence concerns the gene NRP1 and cancer.